Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
(NASDAQ: CMND) Delayed: 0.79 -0.01 (1.25%)
Previous Close $0.80    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.78    EPS $ 
Volume 121,023